Targeting miR-155 as a therapy for mucolipidosis IV
Awardee: Susan Slaugenhaupt
Institution: Massachusetts General Hospital
Award Amount: $50,000
Funding Period: January 1, 2015 - December 31, 2015
Previous
Previous
Unraveling the basis of white matter disease in mucopolysaccharidosis type I – a DTI study
Next
Next